6533b7d4fe1ef96bd1262078

RESEARCH PRODUCT

Gold(I)-Coumarin-Caffeine-Based Complexes as New Potential Anti-Inflammatory and Anticancer Trackable Agents.

Jean-louis ConnatBenoît BertrandSouheila AmorPierre Le GendreFlorian ChotardEwen BodioCatherine PaulCatherine PaulAli BettaiebAli BettaiebPhilippe RichardAudrey Trommenschlager

subject

Fluorophoremedicine.drug_classUltraviolet RaysAnti-Inflammatory AgentsAntineoplastic Agents010402 general chemistry01 natural sciencesBiochemistryAnti-inflammatoryFluorescencechemistry.chemical_compoundCoordination ComplexesCoumarinsCaffeineCell Line TumorDrug DiscoverymedicineHumansGeneral Pharmacology Toxicology and PharmaceuticsFluorescent DyesPharmacology010405 organic chemistryOrganic ChemistryCancerCoumarinmedicine.diseaseCombinatorial chemistryIn vitro0104 chemical sciencesHEK293 CellsMicroscopy Fluorescence MultiphotonchemistryMolecular MedicineGoldCancer cell linesCaffeine

description

Three new gold(I)-coumarin-based trackable therapeutic complexes and two non-trackable analogues have been synthesised and fully characterised. They all display anti-proliferative properties on several types of cancer cell lines, including those of colon, breast, and prostate. Two complexes displayed significant anti-inflammatory effects; one displayed pro-inflammatory behaviour; this highlights the impact of the position of the fluorophore on the caffeine scaffold. Additionally, the three coumarin derivatives could be visualised in vitro by two-photon microscopy.

10.1002/cmdc.201800474https://pubmed.ncbi.nlm.nih.gov/30203922